ViroPharma Inc. Sets New 1-Year High at $49.91 (VPHM)
Shares of ViroPharma (NASDAQ:VPHM) hit a new 52-week high during trading on Wednesday, Analyst Ratings Network reports. The stock traded as high as $49.91 and last traded at $49.85, with a volume of 713,299 shares trading hands. The stock had previously closed at $49.89.
A number of research firms have recently commented on VPHM. Analysts at Stifel Nicolaus downgraded shares of ViroPharma from a “buy” rating to a “hold” rating in a research note to investors on Tuesday, November 19th. They now have a $47.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. downgraded shares of ViroPharma from an “overweight” rating to a “neutral” rating in a research note to investors on Tuesday, November 12th. They now have a $50.00 price target on the stock, up previously from $45.00. Finally, analysts at Piper Jaffray downgraded shares of ViroPharma from an “overweight” rating to a “neutral” rating in a research note to investors on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $39.23.
ViroPharma has a 1-year low of $23.13 and a 1-year high of $49.91. The stock has a 50-day moving average of $49.68 and a 200-day moving average of $38.74. The company’s market cap is $3.282 billion.
ViroPharma (NASDAQ:VPHM) last released its earnings data on Thursday, October 24th. The company reported $0.20 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.05 by $0.15. The company had revenue of $113.00 million for the quarter, compared to the consensus estimate of $113.35 million. During the same quarter in the prior year, the company posted $0.10 earnings per share. The company’s quarterly revenue was up 24.3% on a year-over-year basis. On average, analysts predict that ViroPharma will post $-0.76 earnings per share for the current fiscal year.
ViroPharma Incorporated (NASDAQ:VPHM) is an international biotechnology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.